Skip to main content
Equibles

BDRX · Biodexa Pharmaceuticals Plc · Financials

Track BDRX — free

Use BDRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BDRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.38 -0.03 (-7.25%)
Rebalance outlook locked
Market Cap
$896,022
Shares
2.20M
Volume · Oct 22 96.37K Avg daily vol (3M) 4.86M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
381K -45.5%
FY2023 Revenue FY2015–FY2023
Net Income
-6.38M -11.4%
FY2025 Net Income FY2017–FY2025
Gross Margin
674.62% +201.8pp
FY2017 Gross Margin FY2015–FY2017
Operating Margin
-2103.41% -825.6pp
FY2023 Operating Margin FY2015–FY2023
Diluted EPS
-0.00 +90%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-5.59M +54.4%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2020 FY2019 FY2017 FY2016 FY2015
GBP — — 926K 667K 70K
GBP — — 6.67M 6.26M 1.31M
GBP 6000 323K 170K 12.51M 605K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2025-12-31 GBP 61,000 6-K filed 2026-09-11
Current borrowings, including current portion of noncurrent borrowings 2025-12-31 GBP 61,000 20-F filed 2026-03-27
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1643918 CUSIP 59564R872 13F (30d) 1 filings 1 filers Visit website Investor relations